drugset / Trial / NCT05989165

Effectiveness of Combination Therapy of Microneedling and Minoxidil in Androgenetic Alopecia of Indonesian Men

NCT05989165 ↗

Phase 3 Completed 36 enrolled Indonesia University
RandomizedParallel-groupOpen-labelTreatment

Summary

The goal of this clinical trial is to compare the effectiveness of combination therapy of microneedling and minoxidil in androgenetic alopecia of Indonesian men. The main questions it aims to answer are: * Is there an increase in hair density with combination therapy of microneedling and minoxidil versus minoxidil monotherapy? * Is there an increase in hair diameter with combination therapy of microneedling and minoxidil versus minoxidil monotherapy? Participants will be divided into 2 groups. The first one will receive minoxidil monotherapy, and the second one will receive a combination therapy of microneedling and minoxidil. Researchers will compare those 2 groups to see if there is a difference of effectiveness based on hair density and diameter.

Timeline

Start
2023-06-01
Primary completion
2023-09-01
Completion
2023-09-15

Outcome

Met primary endpoint

paper CONCLUSION: Dermaroller along with Minoxidil treated group was statistically superior to Minoxidil treated group in promoting hair growth in men with AGA for all 3 primary efficacy measures of hair growth. PMID 23960389 ↗

paper CONCLUSION: Our study showed that the combination of microneedling and topical minoxidil treatment was superior compared to topical minoxidil alone with regard to increase in the hair count and patient satisfaction PMID 30886475 ↗

Drugs

EvaluationDrugModalityDoseRoute
Subject Minoxidil Small molecule 5 % Topical

Indications